DÄ internationalArchive44/2014Prophylactic Vaccination
LNSLNS

Unfortunately, vaccination to prevent pneumonia is not mentioned in the article (1). Its efficacy and indication remain unclear. Some European countries do not recommend this vaccination at all, for example Belgium, Denmark, Estonia, Finland, and Poland, or limited it to special risk situations, for example France, Italy, Monaco, and Norway (this selection is not comprehensive; for more detailed information see [2]).

We shall have to wait for the publication of the now completed Pfizer-sponsored CAPiTA study (see clinicaltrials.gov) on the efficacy of the 13-valent Prevanar vaccine in adults older than 65 years.

Still I would be grateful to hear the authors’ opinion on this extremely important topic.

DOI: 10.3238/arztebl.2014.0757b

Dr. med. Joachim Pries

AfA, Korbach
priesj@staff.uni-marburg.de

1.
Holzinger F, Beck S, Dini L, Stöter C, Heintze C: The diagnosis and treatment of acute cough in adults. Dtsch Arztebl Int 2014; 111: 356–63. VOLLTEXT
2.
WHO: Immunization, vaccines and biologicals. www.who.int/immunization/monitoring_surveillance/en/ (last accessed on 16 July 2014)
1.Holzinger F, Beck S, Dini L, Stöter C, Heintze C: The diagnosis and treatment of acute cough in adults. Dtsch Arztebl Int 2014; 111: 356–63. VOLLTEXT
2.WHO: Immunization, vaccines and biologicals. www.who.int/immunization/monitoring_surveillance/en/ (last accessed on 16 July 2014)

Info

Specialities